Cell Biosciences, Inc.. (10/28/09). "Press Release: Cell Biosciences Completes Acquisition of Alpha Innotech". Santa Clara, CA.

	Organisation	Alpha Innotech Corporation
	Group	Cell Biosciences (Group)
	Product	proteomics
	Product 2	laboratory equipment and instruments
	Index term	Alpha Innotech–Cell Biosciences: investment, 200909–200910 aquisition $17.9m in cash $1.5/share by Cell Biosciences

Cell Biosciences, Inc. today announced that it has completed its acquisition of Alpha Innotech Corp. (OTC BB: APNO.OB). The stockholders of Alpha Innotech have approved the transaction, and all regulatory and other conditions have been satisfied. Pursuant to the merger agreement announced on September 8, 2009, former Alpha Innotech stockholders will receive $1.50 per share, or approximately $17.9 million in cash.

About Cell Biosciences

Cell Biosciences is a private life sciences company focused on nanoproteomics. The Company develops instrumentation systems, software, and assay products that reveal previously undetectable information about cellular control pathways. Its customers include leading institutions in the fields of cancer research, stem cell biology, and diabetes. Cell Biosciences' products enable researchers to uncover fundamental mechanisms controlling cell proliferation and cell death, to accelerate the development of new therapeutics, and to help identify new prognostic and diagnostic disease biomarkers. Cell Biosciences is located in Santa Clara, California. For more information, visit www.cellbiosciences.com.

CONTACT: Tim Harkness, CEO, Cell Biosciences, Inc., (408) 510-5501, tharkness@cellbiosciences.com

Record changed: 2011-11-25

Follow Us!

Top News

Upcoming Events

Associations

Partners

Cell Biosciences, Inc.. (10/28/09). "Press Release: Cell Biosciences Completes Acquisition of Alpha Innotech". Santa Clara, CA.

More documents for Cell Biosciences (Group)